Publications
-
What is the difference between an Invention Patent and a Utility Model Patent?
- August 16, 2021
- Posted by: admin
- Category: Publications
No CommentsEIP Patent 101 Corner What is the difference between an Invention Patent and a Utility Model Patent? August 2021 There are two types of patent protection in China. Invention patents (similar to a US utility patent) have a term of 20 years from the date of filing and may be granted for both methods and -
New Draft Patent Examination Guidelines are Available for Public Comment
- August 4, 2021
- Posted by: admin
- Category: Publications
New Draft Patent Examination Guidelines are Available for Public Comment August 2021 Two months after the new Chinese Patent law came into effect, the CNIPA has released a new set of Patent Examination Guidelines (proposed version) for public comments today (3 Aug 2021). Here are the explanation of the amendments (Chinese only). Here is the -
China Top 10 Cases of 2020 – Winners’ Sun is truly a Winner: A Simple Selfie – Stick Utility Model Patent Crushes Infringers in China
- August 3, 2021
- Posted by: admin
- Category: Publications
China Top 10 Cases of 2020 – Winners’ Sun is truly a Winner: A Simple Selfie - Stick Utility Model Patent Crushes Infringers in China August 2021 Each year The Intellectual Property Tribunal of the Supreme People’s Court releases a list of top 10 technical intellectual property rights. The 2020 list came out a few -
Breaking: China Released New Implementation Measures for the New Patent Linkage System
- July 15, 2021
- Posted by: admin
- Category: Publications
Breaking: China Released New Implementation Measures for the New Patent Linkage System July 2021 On July 4, 2021, China’s National Medical Products Administration (NMPA) and the China National Intellectual Property Administration (CNIPA) released details on the new implementation measures for early dispute resolution mechanisms for drug patents (“Patent Linkage”), effective July 4, 2021. Below is -
China Top 10 Patent Re-Examination and Invalidation Cases of 2020 CNIPA Upholds Bayer’s Rivaroxaban Patent
- June 9, 2021
- Posted by: admin
- Category: Publications
China Top 10 Patent Re-Examination and Invalidation Cases of 2020 CNIPA Upholds Bayer's Rivaroxaban Patent June 2021 The development of China's approach to patents, especially those in the pharmaceutical and biotech space, has been fascinating to watch. Those of us who have practiced in the area for a long time have been frustrated by the -
CNIPA Releases Interim Measures for the Amended Chinese Patent Law Going Into Effect June 1, 2021
- May 28, 2021
- Posted by: admin
- Category: Publications
CNIPA Releases Interim Measures for the Amended Chinese Patent Law Going Into Effect June 1, 2021 May 2021 Breaking News! We finally have more details about the new Chinese Patent Law which will go into effect on June 1, 2021. The full set of measure can be found at this link. Below are some pertinent -
China Top 10 Cases of 2020 – CNIPA Upholds Second Medical Use Patent from University of Bordeaux
- May 24, 2021
- Posted by: admin
- Category: Publications
China Top 10 Cases of 2020 – CNIPA Upholds Second Medical Use Patent from University of Bordeaux May 2021 The development of China’s approach to patents, especially those in the pharmaceutical and biotech space, has been fascinating to watch. Those of us who have practiced in the area for a long time have been frustrated -
China’s Newest Examination Guidelines: Inventive Step for Biological / Life Science Inventions (Part III)
- April 28, 2021
- Posted by: admin
- Category: Publications
China’s Newest Examination Guidelines: Inventive Step for Biological / Life Science Inventions (Part III) April 2021 This is Part III of a three-part series summarizing the Examination Guidelines that were released by the CNIPA on January 15, 2021. Part I of this series covers examples on post-filing supplemental data. Part II covers examples on novelty -
China’s Newest Examination Guidelines: Novelty and Inventive Step for Compounds (Part II)
- April 28, 2021
- Posted by: admin
- Category: Publications
China’s Newest Examination Guidelines: Novelty and Inventive Step for Compounds (Part II) April 2021 This is Part II of a three-part series summarizing the Examination Guidelines that were released by the CNIPA on January 15, 2021. Part I of this series covers examples on post-filing supplemental data. Part II covers examples on novelty and inventive -
China Adds Europe as a Searching Authority for PCT Applications
- April 28, 2021
- Posted by: admin
- Category: Publications
China Adds Europe as a Searching Authority for PCT Applications February 2021 China has recently initiated a new pilot program adding the European Patent Office as a searching authority option for PCT (Patent Cooperation Treating) international applications filed with CNIPA (Chinese National Intellectual Property Administration) as the receiving office (RO). Previously, applicants filing a PCT